These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17019890)

  • 1. Function and dysfunction of monoamine interactions in children and adolescents with AD/HD.
    Oades RD
    EXS; 2006; 98():207-44. PubMed ID: 17019890
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential measures of 'sustained attention' in children with attention-deficit/hyperactivity or tic disorders: relations to monoamine metabolism.
    Oades RD
    Psychiatry Res; 2000 Mar; 93(2):165-78. PubMed ID: 10725533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of conditioned blocking and monoamine metabolism in children with attention-deficit-hyperactivity disorder or complex tics and healthy controls: an exploratory analysis.
    Oades RD; Müller B
    Behav Brain Res; 1997 Oct; 88(1):95-102. PubMed ID: 9401713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selegiline in ADHD adults: plasma monoamines and monoamine metabolites.
    Ernst M; Liebenauer LL; Tebeka D; Jons PH; Eisenhofer G; Murphy DL; Zametkin AJ
    Neuropsychopharmacology; 1997 Apr; 16(4):276-84. PubMed ID: 9094145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder.
    de Villiers AS; Russell VA; Sagvolden T; Searson A; Jaffer A; Taljaard JJ
    Neurochem Res; 1995 Apr; 20(4):427-33. PubMed ID: 7651580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disinhibition in children with attention-deficit/hyperactivity disorder: Changes in [oxy-Hb] on near-infrared spectroscopy during "rock, paper, scissors" task.
    Ishii S; Kaga Y; Tando T; Aoyagi K; Sano F; Kanemura H; Sugita K; Aihara M
    Brain Dev; 2017 May; 39(5):395-402. PubMed ID: 28094161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive deficits in major depression and a new theory of ADHD: a model of impaired antagonism of cholinergic-mediated prepotent behaviours in monoamine depleted individuals.
    Vakalopoulos C
    Med Hypotheses; 2007; 68(1):210-21. PubMed ID: 16997497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Monoaminergic System in Thyroid Hormone Receptor-β Deficient Mice as a Model of Attention-Deficit/Hyperactivity Disorder.
    Ookubo M; Sadamatsu M; Yoshimura A; Suzuki S; Kato N; Kojima H; Yamada N; Kanai H
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyv004. PubMed ID: 25612897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aiding diagnosis of attention-deficit/hyperactivity disorder and its subtypes: discriminant function analysis of event-related potential data.
    Smith JL; Johnstone SJ; Barry RJ
    J Child Psychol Psychiatry; 2003 Oct; 44(7):1067-75. PubMed ID: 14531589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder.
    Hiraide S; Ueno K; Yamaguchi T; Matsumoto M; Yanagawa Y; Yoshioka M; Togashi H
    Pharmacol Biochem Behav; 2013 Apr; 105():89-97. PubMed ID: 23380523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient screening of Japanese children with epilepsy for attention-deficit/hyperactivity disorder (AD/HD).
    Tanabe T; Kashiwagi M; Shimakawa S; Tamai H; Wakamiya E
    Brain Dev; 2014 Apr; 36(4):301-5. PubMed ID: 23756293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Back to where it all started: monoamines and behavior--from drug responses to genes.
    Licinio J; Wong ML
    Mol Psychiatry; 2004 May; 9(5):427. PubMed ID: 15118733
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of attention-deficit-hyperactivity disorder and conduct disorder in Mexican children by the scale for evaluation of deficit of attention and hyperactivity.
    Zambrano-Sánchez E; Martínez-Cortés JA; Del Rió-Carlos Y; Martínez-Wbaldo Mdel C; Poblano A
    Psychiatry Res; 2011 May; 187(3):437-40. PubMed ID: 20934222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a specific polysomnographic sleep pattern in children with attention deficit/hyperactivity disorder?
    Kirov R; Kinkelbur J; Heipke S; Kostanecka-Endress T; Westhoff M; Cohrs S; Ruther E; Hajak G; Banaschewski T; Rothenberger A
    J Sleep Res; 2004 Mar; 13(1):87-93. PubMed ID: 14996040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurobiology of attention deficit hyperactivity disorder].
    Wankerl B; Hauser J; Makulska-Gertruda E; Reißmann A; Sontag TA; Tucha O; Lange KW
    Fortschr Neurol Psychiatr; 2014 Jan; 82(1):9-29. PubMed ID: 24446115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychostimulants and monoamine transporters: upsetting the balance.
    Elliott JM; Beveridge TJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):94-100. PubMed ID: 15661632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and electroencephalographic disturbances in children with attention-deficit/hyperactivity disorder and sleep problems: new insights.
    Sawyer AC; Clark CR; Keage HA; Moores KA; Clarke S; Kohn MR; Gordon E
    Psychiatry Res; 2009 Dec; 170(2-3):183-91. PubMed ID: 19854519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Involvement of vesicular monoamine transporter in attention deficit hyperactivity disorder].
    Lorenzo-Sanz G; Sánchez-Herranz A
    Rev Neurol; 2011 Mar; 52 Suppl 1():S103-8. PubMed ID: 21365590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Children with attention deficit/hyperactivity disorder and pervasive developmental disorder:attention and response inhibition in the kiddie continuous performance test].
    Tsushima Y; Sanada S; Yanagihara M; Ohno S; Hirasawa T; Oka M; Ogino T; Ohtsuka Y
    No To Hattatsu; 2011 Sep; 43(5):367-71. PubMed ID: 21941843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical necessity for assessing Attention Deficit/Hyperactivity Disorder (AD/HD) symptoms in children with high-functioning Pervasive Developmental Disorder (PDD).
    Yoshida Y; Uchiyama T
    Eur Child Adolesc Psychiatry; 2004 Oct; 13(5):307-14. PubMed ID: 15490278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.